Zobrazeno 1 - 10
of 1 100
pro vyhledávání: '"R. Hohlfeld"'
Autor:
R. Hohlfeld, K. v. Toyka
Publikováno v:
Myasthenia Gravis ISBN: 9780429276750
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac3bcd8408661a3a1460eb812a265b34
https://doi.org/10.1201/9780429276750-7
https://doi.org/10.1201/9780429276750-7
Autor:
H. Wekerle, R. Hohlfeld
Publikováno v:
Der Nervenarzt. 86:925-933
The individual risk of contracting multiple sclerosis (MS) is determined by genetic predisposition as well as environmental factors. In monozygotic twins the concordance rate for MS is approximately 30 % indicating that environmental factors are even
Publikováno v:
Der Internist. 56:432-445
Die multiple Sklerose (MS) ist eine Autoimmunerkrankung des zentralen Nervensytems mit charakteristischen entzundlichen Veranderungen der weisen und grauen Substanz. Wahrscheinlich als Folge der Demyelinisierung kommt es bereits fruhzeitig zu einem i
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L, Klotz, A, Berthele, W, Brück, A, Chan, P, Flachenecker, R, Gold, A, Haghikia, K, Hellwig, B, Hemmer, R, Hohlfeld, T, Korn, T, Kümpfel, M, Lang, V, Limmroth, R A, Linker, U, Meier, S G, Meuth, F, Paul, A, Salmen, M, Stangel, B, Tackenberg, H, Tumani, C, Warnke, M S, Weber, T, Ziemssen, F, Zipp, H, Wiendl
Publikováno v:
Klotz, L; Berthele, A; Brück, W; Chan, Andrew; Flachenecker, P; Gold, R; Haghikia, A; Hellwig, K; Hemmer, B; Hohlfeld, R; Korn, T; Kümpfel, T; Lang, M; Limmroth, V; Linker, R A; Meier, U; Meuth, S G; Paul, F; Salmen, Anke; Stangel, M; ... (2016). [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt, 87(6), pp. 645-659. Springer 10.1007/s00115-016-0077-1
With the approval of various substances for the immunotherapy of multiple sclerosis (MS), treatment possibilities have improved significantly over the last few years. Indeed, the choice of individually tailored preparations and treatment monitoring f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::45d31251ff42ca58963d60e5031f3d04
https://boris.unibe.ch/87818/1/art%3A10.1007%2Fs00115-016-0077-1.pdf
https://boris.unibe.ch/87818/1/art%3A10.1007%2Fs00115-016-0077-1.pdf
Autor:
H. Wekerle, R. Hohlfeld
Strong evidence supports an autoimmune pathogenesis of multiple sclerosis (MS), but the ultimate trigger has remained unknown. In addition to infective agents, recently the commensal gut flora has emerged as suspect. Studies of spontaneous experiment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47d7440c93e9baff2b182c5c87a65bbe
https://doi.org/10.1016/b978-0-12-801914-6.00009-x
https://doi.org/10.1016/b978-0-12-801914-6.00009-x
Autor:
K.V. Toyka, R. Hohlfeld
Publikováno v:
Der Nervenarzt. 82:1026-1035
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the Neurological Sciences. 274:5-8
In experimental autoimmune encephalomyelitis (EAE), several target antigens of encephalitogenic T- and B-cell responses have been identified. However, in human multiple sclerosis (MS) the target antigens of pathogenic T and B cells have remained conj
Publikováno v:
Neurology. 71:1350-1354
Natalizumab, a humanized anti-alpha4 integrin monoclonal antibody, reduces relapses and disease progression in patients with multiple sclerosis (MS). Whereas its presumed mode of action is inhibition of T cell/monocyte entry into the brain, little is